<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[SAIF Partners IV L.P. 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=48269></link><description><![CDATA[SAIF Partners IV L.P. 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Sat, 02 May 2026 18:15:45 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2025/06/12_31017998_20250617151610_1463629950.png]]></url></image><language>ko-KR</language><item><title><![CDATA[Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special Meeting]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1014614</link><description><![CDATA[NEW YORK--(Business Wire/Korea Newswire)--SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), today announced that Sinovac Biotech Ltd. (“Sinovac” or the “Company”) shareholders voted to approve SAIF Partners’ proposals to remove the Company’s incumbent directors and to elect SAIF Partners’ slate of ten highly qualified director nominees to the Board of Directors (the “Board”) at Si...]]></description><pubDate>Wed, 09 Jul 2025 14:57:16 +0900</pubDate></item><item><title><![CDATA[SAIF Partners: Now is Your Last Chance to Vote for Board Change at Sinovac]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1014298</link><description><![CDATA[NEW YORK--(Business Wire/Korea Newswire)--SAIF Partners IV L.P., (“SAIF Partners”, “we” or “us”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”) which beneficially owns approximately 15% of the Company’s outstanding common shares, today urged shareholders to immediately vote “FOR” the election of SAIF Partners’ ten highly qualified director candidates t...]]></description><pubDate>Thu, 03 Jul 2025 13:15:41 +0900</pubDate></item><item><title><![CDATA[SAIF Partners Sends Open Letter to Sinovac Shareholders Outlining Current Board’s Failure to Act in the Interests of Shareholders]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013768</link><description><![CDATA[BEIJING--(Business Wire/Korea Newswire)--SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, today sent a letter to its fellow Sinovac shareholders exposing the current Sinovac Board’s failure to act in the interest of all shareholders resultin...]]></description><pubDate>Wed, 25 Jun 2025 17:15:00 +0900</pubDate></item><item><title><![CDATA[SAIF 파트너스, 시노백 주주들에게 공개서한 발송… 현 이사회의 주주 이익 위한 직무 유기]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013769</link><description><![CDATA[베이징, 중국--(Business Wire/뉴스와이어)--시노백 바이오테크(Sinovac Biotech Ltd., 이하 시노백 또는 회사)의 최대 단일 투자자로서 발행 보통주의 약 15%를 실질적으로 소유한 SAIF 파트너스(SAIF Partners IV L.P., 이하 SAIF 파트너스)가 동료 주주들에게 서한을 발송해 현 시노백 이사회가 모든 주주의 이익을 위해 행동하지 않아 주주 배당금 지급 및 6년간 중단된 주식 거래 재개에 실패했음을 폭로했다.  이...]]></description><pubDate>Wed, 25 Jun 2025 17:15:00 +0900</pubDate></item><item><title><![CDATA[SAIF Partners Files Definitive Proxy Materials in Connection with Sinovac Biotech 2025 Special Meeting of Shareholders; Nominates Ten Highly Qualified Director Candidates to the Board]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013422</link><description><![CDATA[BEIJING--(Business Wire/Korea Newswire)--SAIF Partners IV L.P., (“SAIF Partners”), the largest single investor in Sinovac Biotech Ltd. (“Sinovac” or the “Company”), beneficially owning approximately 15% of the outstanding common shares, today announced that it has filed a definitive proxy statement for the election of ten director nominees to Sinovac’s Board of Directors (the “Board”) ...]]></description><pubDate>Thu, 19 Jun 2025 14:00:00 +0900</pubDate></item><item><title><![CDATA[SAIF 파트너스, 시노백 바이오텍 2025 특별 주주총회 관련 최종 위임장 자료 제출… 이사회에 뛰어난 자격을 갖춘 이사 후보 10명 지명]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1013423</link><description><![CDATA[베이징, 중국--(Business Wire/뉴스와이어)--시노백 바이오텍(Sinovac Biotech Ltd., 이하 시노백 또는 회사)의 최대 단일 투자자로서 발행 보통주의 약 15%를 실질적으로 소유하고 있는 SAIF 파트너스 IV(SAIF Partners IV L.P., 이하 SAIF 파트너스)는 오는 7월 8일 화요일 오후 8시(대서양 표준시)(7월 9일 수요일 오전 8시, 중국 표준시)에 개최되는 특별 주주총회 및 연기, 계속 또는 일정이 변경된 모든 회의(이...]]></description><pubDate>Thu, 19 Jun 2025 14:00:00 +0900</pubDate></item></channel></rss>